MBX stock

MBX Biosciences, Inc. Common Stock (MBX) financials · $1.98B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

MBX Biosciences, Inc. Common Stock (MBX) $1.98B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$98.1M-$68.2M
Net Income-$87.0M-$61.9M
EPS (Diluted)-$2.38-$5.82
Cached annual balance sheet
LineFY2025FY2024
Total Assets$385.1M$268.5M
Current Assets$381.5M$267.3M
Cash & Equivalents$75.3M$49.4M
PP&E$2.73M$1.08M
Total Liabilities$15.9M$11.1M
Current Liabilities$15.5M$11.1M
Shareholders' Equity$369.2M$257.4M
Retained Earnings-$224.5M-$137.5M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$79.9M-$54.7M
CapEx$1.93M$874.0K
Investing Cash Flow-$83.7M-$160.6M
Financing Cash Flow$189.6M$234.1M
Net Change in Cash$25.9M$18.8M
Free Cash Flow-$81.9M-$55.6M
These statements as JSON? API free 100/day

FAQ

What is MBX P/E and revenue?

MBX Biosciences, Inc. Common Stock (MBX) $1.98B cap.

What is MBX revenue?

MBX income-statement cache has no revenue figure yet.

Is MBX profitable?

MBX Biosciences, Inc. Common Stock last cached net income is -$87.0M (FY2025).

What are MBX total assets?

MBX Biosciences, Inc. Common Stock last cached total assets are $385.1M (FY2025).

What is MBX free cash flow?

MBX Biosciences, Inc. Common Stock last cached free cash flow is -$81.9M (FY2025).

Not investment advice. Cached statements, not a live tape.